Cell Signaling Technology

Phospho-ATM/ATR Substrate Motif [(pS/pT) QG] MultiMab® Rabbit Monoclonal Antibody mix

#6966 · western blot · $194,446

100

Citing papers

3.4k

Combined citations

Supplier page Find this product

Research areas

RNA modifications and cancer8 Epigenetics and DNA Methylation6 Protein Kinase Regulation and GTPase Signaling5 Ion Channels and Receptors5 Immunotherapy and Immune Responses5 DNA Repair Mechanisms5 PI3K/AKT/mTOR signaling in cancer5 RNA Research and Splicing5

Papers citing this product

1

<i>Circ0008399</i> Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer

Cancer Research·2021·170 cit.·DOI

2

Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study

BMC Cancer·2014·144 cit.·DOI

3

Arrest of Myelination and Reduced Axon Growth When Schwann Cells Lack mTOR

Journal of Neuroscience·2012·138 cit.·DOI

4

Spatiotemporally programmable cascade hybridization of hairpin DNA in polymeric nanoframework for precise siRNA delivery

Nature Communications·2021·130 cit.·DOI

5

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC

Cell Death and Disease·2017·107 cit.·DOI

6

Stt7-dependent Phosphorylation during State Transitions in the Green Alga Chlamydomonas reinhardtii

Molecular & Cellular Proteomics·2010·97 cit.·DOI

7

Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer

Journal of Cancer·2020·96 cit.·DOI

8

MUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling

Molecular Cancer Research·2006·89 cit.·DOI

9

Increased cAMP Levels Modulate Transforming Growth Factor-β/Smad-induced Expression of Extracellular Matrix Components and Other Key Fibroblast Effector Functions

Journal of Biological Chemistry·2009·84 cit.·DOI

10

Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ–stimulated antitumor immunity

Journal of Clinical Investigation·2022·80 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.